Chargement en cours...
Metastatic, Her-2 Amplified Lacrimal Gland Carcinoma with Response to Lapatinib Treatment
Carcinoma of the lacrimal gland is a rare malignancy, limiting opportunities to develop new therapeutic regimens through clinical trials. There are no standard guidelines on optimal treatment of lacrimal gland carcinoma. In addition, lacrimal gland carcinoma includes several different subtypes with...
Enregistré dans:
| Publié dans: | Case Rep Oncol Med |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4332983/ https://ncbi.nlm.nih.gov/pubmed/25722902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/262357 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|